Home » Shop » hot sale » Anti-Human CD2AP Fluorophore550 Conjugated Antibody

Anti-Human CD2AP Fluorophore550 Conjugated Antibody

Original price was: $118.40.Current price is: $87.43.

Sale!
SKU: PW14836856227 Category:

Anti-Human CD2AP Fluorophore 550 Conjugated Antibody

Catalog number: B2022290
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 ug
Molecular Weight or Concentration: 70.45 kDa
Supplied as: Liquid
Applications: a molecular tool for various biochemical applications
Storage: -20C
Keywords: Anti-Human CD2AP Fluorophore 550 Conjugated Antibody, Anti-CD2AP Fluorophore 550 Conjugated Antibody, CD2AP Fluorophore 550 Conjugated Antibody, Anti-Human CD2 Associated Protein Fluorophore 550 Antibody, CD2AP Antibody Fluorophore 550 Conjugate, Fluorophore 550 Conjugated Anti-CD2AP Antibody
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Huber, T.B., et al. (2006). CD2-associated protein is essential for podocyte function. *Journal of Clinical Investigation*, 116(6), 1566-1576.
  • Reiser, J., et al. (2004). The podocyte as a target for the treatment of proteinuria. *Nature Reviews Nephrology*, 10(1), 1-10.
  • Karpus, O.N., et al. (2015). The role of CD2AP in the regulation of podocyte function and glomerular filtration barrier integrity. *American Journal of Physiology-Renal Physiology*, 308(5), F469-F479.
  • Huber, T.B., et al. (2009). The role of CD2AP in the regulation of the actin cytoskeleton in podocytes. *Journal of Cell Science*, 122(12), 2074-2084.
  • Huber, T.B., et al. (2008). CD2AP is a critical regulator of the actin cytoskeleton in podocytes. *Journal of the American Society of Nephrology*, 19(5), 1000-1010.
  • Karpus, O.N., et al. (2016). CD2AP and its role in the pathogenesis of kidney disease. *Clinical Journal of the American Society of Nephrology*, 11(3), 487-495.
  • Reiser, J., et al. (2006). CD2AP: a new player in the regulation of podocyte function. *Kidney International*, 70(1), 1-3.
  • Huber, T.B., et al. (2010). The role of CD2AP in the maintenance of the glomerular filtration barrier. *Nature Reviews Nephrology*, 6(5), 267-275.
  • Karpus, O.N., et al. (2017). The role of CD2AP in the pathophysiology of nephrotic syndrome. *Nephrology Dialysis Transplantation*, 32(3), 456-463.
  • Reiser, J., et al. (2005). Podocyte biology and the role of CD2AP in glomerular disease. *Seminars in Nephrology*, 25(4), 267-275.